Icure Pharmaceutical's Shareholders' Meeting Petition Withdrawn by IK Partners Group, Reducing Management Dispute Risk
Icure Pharmaceutical disclosed that the petition for permission to convene a shareholders' meeting filed by IK Partners and 75 others has been withdrawn.
This is related to the management dispute lawsuit filed on March 9, 2026, and the withdrawal suggests a potential resolution of the legal conflict.
The removal of immediate threat to current management is expected to contribute to shareholder value stabilization.
[AI Summary]Withdrawal of management dispute without capital changes reduces governance risk, positive for short-term stock price stability.
KOSDAQ Filing Information
Judgment/Decision on Lawsuit, etc. (Permission to Convene a General Meeting of Shareholders)